Schedule 13G ownership disclosure

EAGLE PHARMACEUTICALS INC

Common stock, $0.001 par value per share · CUSIP: 269796108

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Union Square Park Partners, LP

    Shares: 1,485,677.00 · Class: 11.44%

  • Union Square Park Capital Management, LLC

    Shares: 1,485,677.00 · Class: 11.44%

  • Union Square Park GP, LLC

    Shares: 1,485,677.00 · Class: 11.44%

  • Leon Zaltzman

    Shares: 1,485,677.00 · Class: 11.44%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-000899
Form type
SCHEDULE 13G/A
Filer
EAGLE PHARMACEUTICALS, INC.
CIK
CIK 827871
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub